one important class missing here is glp-1.
$ victoza promising efficacy w/ established safety:

#nash resolution
victoza 39% vs 9% pbo(48w)
$mdgl 27% vs 6% pbo(36w)

fibrosis improvement
victoza 26% vs 14% pbo(48w)
$mdgl 29% vs 26% pbo(36w)

watch out for semaglutide data 2h19 https://t.co/iuac4dzqgy